US 8075921
Rapamycin-resistant T cells and therapeutic uses thereof
granted A61KA61K2035/122A61K2035/124
Quick answer
US patent 8075921 (Rapamycin-resistant T cells and therapeutic uses thereof) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2035/122, A61K2035/124, A61K2039/57, A61K2239/31